These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3392892)

  • 1. Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in Cushing's syndrome.
    Allolio B; Schulte HM; Kaulen D; Reincke M; Jaursch-Hancke C; Winkelmann W
    Klin Wochenschr; 1988 Apr; 66(8):361-4. PubMed ID: 3392892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects.
    Schulte HM; Benker G; Reinwein D; Sippell WG; Allolio B
    J Clin Endocrinol Metab; 1990 May; 70(5):1426-30. PubMed ID: 2159485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease.
    Greening JE; Brain CE; Perry LA; Mushtaq I; Sales Marques J; Grossman AB; Savage MO
    Horm Res; 2005; 64(3):140-3. PubMed ID: 16192738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etomidate use for Cushing's syndrome caused by an ectopic adrenocorticotropic hormone-producing tumor.
    Johnson TN; Canada TW
    Ann Pharmacother; 2007 Feb; 41(2):350-3. PubMed ID: 17213295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis.
    Drake WM; Perry LA; Hinds CJ; Lowe DG; Reznek RH; Besser GM
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3542-4. PubMed ID: 9768661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transsphenoidal hypophysectomy of a patient with an ACTH-producing pituitary adenoma and an "empty sella" after pretreatment with etomidate].
    Herrmann BL; Mitchell A; Saller B; Stolke D; Forsting M; Frilling A; Mann K
    Dtsch Med Wochenschr; 2001 Mar; 126(9):232-4. PubMed ID: 11256037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome.
    Engelhardt D; Jacob K; Doerr HG
    Klin Wochenschr; 1989 Feb; 67(4):241-7. PubMed ID: 2538676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etomidate infusion at low doses is an effective and safe treatment for severe Cushing's syndrome outside intensive care.
    Constantinescu SM; Driessens N; Lefebvre A; Furnica RM; Corvilain B; Maiter D
    Eur J Endocrinol; 2020 Aug; 183(2):161-167. PubMed ID: 32449698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous Etomidate for the Management of Cushing's Syndrome Complicated by Pulmonary Nocardiosis.
    Hays WB; Czosnowski Q
    J Pharm Pract; 2022 Dec; 35(6):1057-1059. PubMed ID: 34056961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
    Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review.
    Preda VA; Sen J; Karavitaki N; Grossman AB
    Eur J Endocrinol; 2012 Aug; 167(2):137-43. PubMed ID: 22577107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D; Weber MM
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease.
    Chan LF; Vaidya M; Westphal B; Allgrove J; Martin L; Afshar F; Hindmarsh PC; Savage MO; Grossman AB; Storr HL
    Horm Res Paediatr; 2011; 75(6):441-6. PubMed ID: 21430362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lipotropin and cortisol responses to an intravenous infusion dexamethasone suppression test in Cushing's syndrome and obesity.
    Abou Samra AB; Dechaud H; Estour B; Chalendar D; Fevre-Montange M; Pugeat M; Tourniaire J
    J Clin Endocrinol Metab; 1985 Jul; 61(1):116-9. PubMed ID: 3998073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.
    Alexandraki KI; Grossman AB
    Drugs; 2016 Mar; 76(4):447-58. PubMed ID: 26833215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
    Krieger DT; Allen W
    J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.